Don't MissBIO in 30: Knock on ‘fast followers,’ all about Hong Kong, & Sculley’s next stop By Casey Ross and Rebecca Robbins June 4, 2018 Reprints BIO in 30: Knock on ‘fast followers,’ all about Hong Kong, & Sculley’s next stop About the Authors Reprints Casey Ross National Technology Correspondent Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. [email protected] @caseymross Rebecca Robbins Health Tech Correspondent Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech. @rebeccadrobbins Tags biotechnology
Don't Miss STAT Staff Introducing the 2023 STATUS List, the definitive accounting of leaders in the life sciences
Business Bob Herman and Casey Ross STAT Plus: Buyer’s remorse: How a Medicare Advantage business is strangling one of its first funders
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
Special Report Jason Mast, Allison DeAngelis and Megan Molteni STAT Plus: CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools
